Investigational Drug Information for Hemay005
✉ Email this page to a colleague
What is the drug development status for Hemay005?
Hemay005 is an investigational drug.
There have been 12 clinical trials for Hemay005.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 15th 2023.
The most common disease conditions in clinical trials are Psoriasis, Behcet Syndrome, and Ulcer. The leading clinical trial sponsors are Tianjin Hemay Pharmaceutical Co.,Ltd, Ganzhou Hemay Pharmaceutical Co., Ltd, and Tianjin Hemay Bio-Tech Co., Ltd.
There is one US patent protecting this investigational drug and seven international patents.
Summary for Hemay005
US Patents | 1 |
International Patents | 7 |
US Patent Applications | 10 |
WIPO Patent Applications | 2 |
Japanese Patent Applications | 2 |
Clinical Trial Progress | Phase 2 (2023-11-15) |
Vendors | 10 |
Recent Clinical Trials for Hemay005
Title | Sponsor | Phase |
---|---|---|
A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease | Ganzhou Hemay Pharmaceutical Co., Ltd | Phase 3 |
A Study of Hemay005 in Adult With Atopic Dermatitis | Ganzhou Hemay Pharmaceutical Co., Ltd | Phase 2 |
Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis | Ganzhou Hemay Pharmaceutical Co., Ltd | Phase 2 |
Clinical Trial Summary for Hemay005
Top disease conditions for Hemay005
Top clinical trial sponsors for Hemay005
US Patents for Hemay005
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Hemay005 | ⤷ Sign Up | Bicyclic compounds and methods of use | BioTheryX, Inc. (Chappaqua, NY) | ⤷ Sign Up |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Hemay005
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Hemay005 | Australia | AU2018285775 | 2037-06-13 | ⤷ Sign Up |
Hemay005 | Canada | CA3065148 | 2037-06-13 | ⤷ Sign Up |
Hemay005 | China | CN110997679 | 2037-06-13 | ⤷ Sign Up |
Hemay005 | European Patent Office | EP3638679 | 2037-06-13 | ⤷ Sign Up |
Hemay005 | Japan | JP2020523295 | 2037-06-13 | ⤷ Sign Up |
Hemay005 | Taiwan | TW201902903 | 2037-06-13 | ⤷ Sign Up |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |